Absolutely thrilled to announce that our portfolio company, Pi-Cardia, has received FDA clearance for their groundbreaking ShortCut device! A huge congratulations to the exceptional team at Pi-Cardia for this well-deserved achievement. We look forward to the positive impact Shortcut will have on patient care.
🚨 𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 𝗡𝗘𝗪𝗦 🚨 We are thrilled to announce that 𝗣𝗶-𝗖𝗮𝗿𝗱𝗶𝗮 𝗵𝗮𝘀 𝗿𝗲𝗰𝗲𝗶𝘃𝗲𝗱 𝗙𝗗𝗔 𝗺𝗮𝗿𝗸𝗲𝘁 𝗰𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗦𝗵𝗼𝗿𝘁𝗖𝘂𝘁 device! 🎉 This is a huge milestone, as we believe ShortCut will be a game-changing leaflet modification solution for the lifetime management of patients with aortic stenosis, addressing coronary obstruction prior to implanting a TAVR. 🫀 Thank you to everyone for your ongoing support, collaboration, and partnership in helping us reach this great achievement! 👏🏻 The full press release can be found in the below link: https://lnkd.in/dmTf8nXf Danny Dvir Didier Tchetche Susheel Kodali Philippe Généreux Benjamin Seguy Philippe Pibarot Hemal Gada Tamim Nazif, MD David Hildick-Smith Nicolas Dumonteil Axel Unbehaun thomas modine Brian Whisenant Christophe Caussin Thomas E. Waggoner, DO, FACC, FSCAI, FSVM, RPVI Jacob Mishell Stanley Chetcuti Saibal Kar Molly Szerlip Ravi Ramana Ran Kornowski Ulrich Gerckens Paolo Denti Ternacle Julien Sabah Skaf MD Jan Kovac Hasan Jilaihawi Vivek Patel Rami Ju'beh Pradeep Yadav Vinod Thourani Edwards Lifesciences Medtronic Abbott Boston Scientific TCTMD PCR EACTS - European Association for Cardio-Thoracic Surgery American College of Cardiology American Heart Association . . . #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves #TAVRenabler